Pricing Log in Create free account

Champions Oncology, Inc. (CSBR) vs Verrica Pharmaceuticals Inc. (VRCA)

Champions Oncology, Inc. and Verrica Pharmaceuticals Inc. are both Biotechnology companies. Champions Oncology, Inc. and Verrica Pharmaceuticals Inc. are of similar size ($66.7M and $64.9M). Verrica Pharmaceuticals Inc. grew revenue faster over the last twelve months: 106.2% against 6.65%. Champions Oncology, Inc. has the higher net margin (−1.87% vs −102.8%) and the lower return on invested capital (−626.2% vs 0.00%). Across the 17 metrics below, Champions Oncology, Inc. leads on 11 and Verrica Pharmaceuticals Inc. on 6.

Valuation

Metric CSBR VRCA Biotechnology median
P/E n/m n/m 8.50
P/S 1.08 2.49 9.71
P/B 14.65 17.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 196.33 n/m 0.64
EV/Sales 1.01 2.56 9.21
Earnings yield (1.70%) (47.18%) (33.15%)
Free cash flow yield (9.36%) (18.02%) (25.50%)

Profitability

Metric CSBR VRCA Biotechnology median
Gross margin 49.82% 85.89% 65.16%
Operating margin (1.68%) (93.59%) 0.00%
Net margin (1.87%) (102.84%) 0.00%
Free cash flow margin (10.08%) (44.02%) 0.00%
Return on equity (28.38%) 473.29% (56.36%)
Return on assets (3.56%) (83.02%) (48.04%)
Return on invested capital (626.23%) 0.00% 0.00%

Growth

Metric CSBR VRCA Biotechnology median
Revenue growth (TTM) 6.65% 106.21% 6.02%
EPS growth (last fiscal year) (124.24%) 88.65% 30.26%
Revenue growth, 5-year CAGR 7.68% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSBR VRCA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 1.03 1.45 4.72
Net debt to EBITDA (20.56) 2.59 0.96

Dividend

Metric CSBR VRCA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CSBR VRCA Biotechnology median
Market cap 66.67m 64.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack